![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||
In vivo time-lapse fluorescence imaging of individual retinal ganglion cells in mice Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Baltimore, MD 21287 Corresponding Author: Mark K. Walsh, Current address: Associated Retinal Consultants, William Beaumont Medical Bldg. #344, 3535 W. Thirteen Mile Rd., Royal Oak, MI 48073, 586-291-4928, 248-288-5644 (fax), Email: walshmk/at/gmail.com The publisher's final edited version of this article is available at J Neurosci Methods.Abstract We have developed a technique that permits time-lapse imaging of retinal ganglion cells (RGCs), their dendritic arbors and their axons in mammals in vivo. This technique utilizes a standard confocal laser scanning microscope, transgenic mice that express yellow fluorescent protein (YFP) in a subset of RGCs and survival anesthesia techniques. The same individual RGCs with their dendritic arbors and axons were multiply imaged in vivo in both adult and juvenile mice. Additionally, the same RGC that was imaged in vivo could then be located and imaged in fixed retinal whole mount preparations. This novel technique has many potential applications. INTRODUCTION A full understanding of dynamic cellular processes would benefit from the ability to observe the same cells over time rather than viewing populations of cells cross-sectionally at various time points (Lichtman and Fraser, 2001). Recently, a convergence of technological advances in molecular biology and fluorescence imaging has made it possible to image individual mammalian neurons and their processes in vivo in time-lapse fashion in both the peripheral nervous system (Walsh and Lichtman, 2003) and in the brain (Grutzendler et al., 2002; Trachtenberg et al., 2002). In the retina, time-lapse imaging of individual RGCs and their dendritic processes has been possible in living zebrafish (Mumm et al., 2006; Zolessi et al., 2006). In mammals, RGC bodies have been imaged in vivo using various imaging techniques (Sabel et al., 1997; Engelmann and Sabel, 1999; Thanos et al., 2002; Cordeiro et al., 2004; Seeliger et al., 2005; Gray et al., 2006; Higashide et al., 2006). For technical reasons, in vivo imaging of individual RGCs and their dendritic arbors, which require higher resolution to image, has not been previously possible in mammals (Chalupa, 2006; Morgan et al., 2005). Time-lapse studies have provided unexpected findings regarding cellular behavior relative to what can be inferred about dynamic processes from sequential time point data (Walsh and Lichtman, 2003; Grutzendler et al., 2002; Trachtenberg et al., 2002; Mumm et al., 2006). Thus, the ability to resolve individual RGCs and their processes in mice over time may provide new avenues of research in both normal neurophysiology and in the study of mutant or disease models. In this report, we describe a novel technique by which individual RGCs along with their dendrites and axons can be imaged in living mice in time-lapse fashion using a readily-available confocal laser scanning microscope with minimal customization. MATERIALS AND METHODS Animals All protocols were approved and monitored by the Animal Care Committee of the Johns Hopkins University School of Medicine and conform to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The YFP-H line of transgenic mice which express cytoplasmic YFP in a small subset of RGCs (Feng et al., 2000) was obtained from The Jackson Laboratory (strain: B6.Cg-Tg(Thy1-YFPH)2Jrs/J; Bar Harbor, Maine). This is one line of many that express spectral variants of GFP under the relatively neuron specific modified Thy1 promoter. Expression of the YFP appears to be innocuous to neuronal development, and neurons tolerate prolonged fluorescence imaging in both the peripheral and central nervous systems (Walsh and Lichtman, 2003; Grutzendler et al., 2002; Feng et al., 2000). Individual lines have different patterns of expression; some have all RGCs labeled, while in others many, few or none are labeled. This variation may be due to modifying effects of genetic sequences near the random location of transgene insertion into the chromosome (Lichtman and Sanes, 2003). For the present work, lines that express in only a subset of RGCs are more advantageous, as this permits the resolution of individual neurons and their processes. At the same time, interpretations of research with these lines are subject to whatever selection bias for RGC expression may be present. In vivo imaging Adult and juvenile mice were anesthetized with an anesthetic cocktail consisting of ketamine 7.5 mg/ml, xylazine 1.3 mg/ml, and acepromazine 0.2 mg/ml (Arras et al., 2001) given intraperitoneally (IP) with a 30 g needle. Injecting half the recommended dosage (0.05 ml/10 gm body weight) IP followed by an injection of ketamine only IP (0.03 ml/10 gm body weight of ketamine 20 mg/ml) 10 min later led to sufficient anesthesia (little or no foot pinch response) in both adult and juveniles for approximately 1 – 2 h with less than 10% of animals dieing from overdose with this technique. We topically anesthetized the cornea with proparacaine 0.5% and dilated the pupil with topical tropicamide 1%. Approximately 1 min later, a drop of viscous hydroxypropyl methylcellulose (Goniosol, CIBA Vision Ophthalmics, Atlanta, GA) was placed on the eye. A glass coverslip (24 mm x 30 mm x 0.13–0.17 mm, Fisher Scientific) was then placed on the eye. This coverslip kept the eye moist throughout the imaging procedure and nullified the refractive power of the mouse’s cornea thus permitting imaging of the retinal plane using the optics of the microscope. Additionally, the coverslip also helped to dampen any motion artifact from the animal’s breathing. The contralateral eye was taped closed to prevent desiccation. The mouse was then placed on a custom-designed (MKW and David Kays, Wilmer Eye Institute) aluminum, heated, microscope stage (Fig. 1
Using proprietary Zeiss image acquisition software, individual RGCs were imaged by focusing deep to the lens and vitreous of the mouse eye with either 5x or 10x air objectives (5x Plan-Apochromat/0.16 numerical aperture (NA), 10x Plan-Neo/0.3 NA, Carl Zeiss Inc.) using the 514 nm argon laser and 530 – 600 nm band pass filter. High quality RGCs images were not able to be obtained with higher magnification and NA lenses available to us. It may be possible to obtain higher quality images with higher NA lenses with varying working distances although ultimate resolution may be limited by aberrations imparted by the mouse eye itself. Due to movement artifact from the mouse’s breathing, high scan speeds were needed, and single z plane images were acquired. Typically, the confocal pinhole aperture was left considerably open in order to optimize fluorescent signal acquisition (see individual figures for specific acquisition settings). After imaging, the coverslip was removed, and the methylcellulose was rinsed from the eye with saline and ophthalmic lubricating ointment (Lacri-Lube, Allergan, Irvine, CA) was placed over the eye. There were no instances of corneal damage or clouding noted either during the imaging sessions or subsequently. The mouse was wrapped in gauze on a plastic bag filled with warm water and allowed to recover. Typically the mouse was active 2 – 4 hr after the initial anesthesia injections. The same mouse could then be re-imaged and survived on a subsequent day using the same imaging protocol. This process can be repeated multiple times over varying time courses as anesthetic lethality was not a significant problem and no instances of corneal damage were noted. Given the small numbers of RGCs that are labeled in each retina, the same individual RGC of interest could be found based on its morphology and neighboring YFP-positive neurons. Whole mount retina Mice were sacrificed by overdose with the above anesthesia. The superior limbus was marked by light cautery for orientation purposes. The eye of interest was then removed using Vannas scissors and forceps with 0.12 mm teeth. The eye was placed in 4% paraformaldehyde in 0.1 M phosphate buffer for 1 hr. The cornea and lens were then removed with Vannas scissors. Relaxing incisions were made in the peripheral retina, and a spatula was used to remove the retina from the retinal pigment epithelium. The retina was mounted on a slide with Vectashield (Vector Laboratories) and a coverslip and imaged with the same confocal microscope used for in vivo imaging (5x, 10x, 20x Plan-Apo/0.75 NA, and 40x oil Plan-Neofluar/1.3 NA objectives, Carl Zeiss Inc.) using the 514 nm argon laser and 530 – 600 nm band pass filter. No image processing or adjustment of signal curves was performed. Figures were made using Adobe Photoshop. RESULTS Fixed tissue imaging: Retinal ganglion cells Approximately 20 transgenic mice expressing YFP, a spectral variant of green fluorescent protein (GFP), in a small subset of RGCs (Feng et al., 2000) were utilized for these studies (The Jackson Laboratory; strain: B6.Cg-Tg(Thy1-YFPH)2Jrs/J; Bar Harbor, Maine). In these mice, typically 50 – 100 RGCs in each retina express YFP (Fig. 2
Fixed tissue imaging: Amacrine cells Out of approximately 500 YFP-positive retinal neurons screened, two were found that appeared to be amacrine cells. In each of these two cases, the cell body stratified to what appeared to be the inner nuclear versus RGC layer and the dendritic arbor was bistratified to the inner plexiform layer with no apparent axon visible (Figs. 4
In vivo imaging By imaging through the mouse cornea-lens axis, YFP-positive axons can be seen entering the optic nerve head in vivo (Fig. 6
Additionally, individual RGCs and their dendritic processes and axons were imaged in juvenile mice (Fig. 9
DISCUSSION We have been able to image individual RGCs with their axons and dendrites multiple times in a living mammal for the first time, to the best of our knowledge. Unlike zebrafish (Mumm et al., 2006; Zolessi et al., 2006), the ocular coats of pigmented transgenic mice, which express cytoplasmic spectral variants of GFP in subsets of neurons (Feng et al., 2000), prevent transscleral (posterior to the mouse cornea) imaging of RGCs using confocal laser scanning microscopy or even multiphoton microscopy (Morgan et al., 2005). Therefore, we viewed retinal neurons through the central visual axis (through the mouse’s cornea and lens) of the mouse eye. The method used a glass coverslip and a coupling agent to create a plano-concave lens on the mouse cornea to permit appropriate focusing of retinal detail. We resolved individual RGCs with their dendritic arborizations and axons in living mice using a standard confocal fluorescence microscope with no customization of the microscope’s optics necessary. Since the mice could be re-anesthetized at later times, we were able to image the same RGC over multiple time points. The same neuron could then be located and imaged in fixed, retinal whole mount preparations after sacrifice. In vivo retinal ganglion cell imaging has also been accomplished in mice (Seeliger et al., 2005), rat (Sabel et al., 1997; Engelmann and Sabel, 1999; Thanos et al., 2002; Cordeiro et al., 2004; Higashide et al., 2006) and macaque (Cordeiro et al., 2004; Gray et al., 2006). These studies utilized either standard epifluorescence microscopy (Thanos et al., 2002), confocal fluorescence microscopy (Sabel et al., 1997; Engelmann and Sabel, 1999), scanning laser ophthalmoscopy (SLO) (Seeliger et al., 2005; Cordeiro et al., 2004; Higashide et al., 2006), or adaptive optics (Gray et al., 2006). In contrast to this previous work, our technique provides a level of RGC imaging resolution not previously seen in mammals. With this technique, it is possible to not only image cell bodies and axons but also dendritic specialization in vivo. Previous work has only allowed for the counting of cell bodies (Sabel et al., 1997; Engelmann and Sabel, 1999; Thanos et al., 2002; Seeliger et al., 2005; Cordeiro et al., 2004; Higashide et al., 2006; Gray et al., 2006) and some visualization of axons (Gray et al., 2006). Several previous techniques also utilized superior colliculus (Sabel et al., 1997, Engelmann and Sabel, 1999; Thanos et al., 2002; Higashide et al., 2006), lateral geniculate (Gray et al., 2006) and intravitreal (Cordeiro et al., 2004) injections in order to label RGCs with fluorescent markers. The limited timecourse of RGC labeling and potential confounders or complications related to injections are eliminated by utilizing transgenic mice which express fluorescent protein cytoplasmically throughout the life of the animal. There are many potential applications of this new technique. For example, one of the authors (HAQ) is developing mouse models for acute and chronic elevations in intraocular pressure. Combining this with in vivo imaging of individual RGCs will permit the study of RGC damage at a cellular level in acute glaucoma in living mice. These mice can also be crossed with various transgenic mouse models of retinal, glaucomatous and optic nerve disease which will permit the study of RGC structural dynamics in these models. Additionally, this imaging technique can be combined with experimental protocols to study the effects of retinal ischemia on RGCs or as an assay for retinal toxicity in pharmacotherapy studies. The in vivo imaging can then be coupled with immunohistochemical studies of tissue from which time-lapse data has already been acquired. Other applications of the method include studies of normal retinal development and the effects of aging. Survival in vivo imaging in mice has been carried out as early as postnatal day 8 (Walsh and Lichtman, 2003), a time at which RGC dendritic segregation is still in its early stages in mice (Landi et al., 2007). Any gross perturbation to dendritic structure or architecture as a response to insult or during normal development (e.g., dendritic segregation) should be resolvable with this technique. This technique should also be applicable to the study of other retinal cell types labeled with GFP variants. Improved axial resolution in the deeper layers of the retina should be possible by utilizing multiphoton fluorescence microscopy. Acknowledgments Thank you to Morton F. Goldberg, David L. Guyton, and Matthew B. Walsh for reviewing the manuscript. Financial support: Harry A. Quigley Research Award from the Wilmer Eye Institute (MKW). NIH grants EY 02120 and 01765 (HAQ). Unrestricted support from the Leonard Wagner Trust, New York, NY (HAQ). Footnotes Presented in part at the Wilmer Resident Association 66th Clinical Meeting, May 18, 2007, Baltimore, MD. No financial disclosures or conflicts of interest for either author. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||
Nat Neurosci. 2001 Nov; 4 Suppl():1215-20.
[Nat Neurosci. 2001]Neuron. 2003 Jan 9; 37(1):67-73.
[Neuron. 2003]Nature. 2002 Dec 19-26; 420(6917):812-6.
[Nature. 2002]Nature. 2002 Dec 19-26; 420(6917):788-94.
[Nature. 2002]Neuron. 2006 Nov 22; 52(4):609-21.
[Neuron. 2006]Neuron. 2000 Oct; 28(1):41-51.
[Neuron. 2000]Neuron. 2003 Jan 9; 37(1):67-73.
[Neuron. 2003]Nature. 2002 Dec 19-26; 420(6917):812-6.
[Nature. 2002]J Neurocytol. 2003 Jun-Sep; 32(5-8):767-75.
[J Neurocytol. 2003]Comp Med. 2001 Oct; 51(5):443-56.
[Comp Med. 2001]Neuron. 2000 Oct; 28(1):41-51.
[Neuron. 2000]Eur J Neurosci. 2005 Mar; 21(5):1257-70.
[Eur J Neurosci. 2005]Neuron. 1998 May; 20(5):971-82.
[Neuron. 1998]Neuron. 2006 Nov 22; 52(4):609-21.
[Neuron. 2006]Neural Dev. 2006 Oct 13; 1():2.
[Neural Dev. 2006]Neuron. 2000 Oct; 28(1):41-51.
[Neuron. 2000]Exp Eye Res. 2005 Mar; 80(3):297-306.
[Exp Eye Res. 2005]Vision Res. 2005 Dec; 45(28):3512-9.
[Vision Res. 2005]Methods Enzymol. 1999; 307():563-70.
[Methods Enzymol. 1999]Trends Neurosci. 2002 Sep; 25(9):441-4.
[Trends Neurosci. 2002]Proc Natl Acad Sci U S A. 2004 Sep 7; 101(36):13352-6.
[Proc Natl Acad Sci U S A. 2004]Invest Ophthalmol Vis Sci. 2006 Jul; 47(7):2943-50.
[Invest Ophthalmol Vis Sci. 2006]Neuron. 2003 Jan 9; 37(1):67-73.
[Neuron. 2003]PLoS One. 2007 Apr 4; 2(4):e346.
[PLoS One. 2007]